High-Dose Melphalan, Etoposide, Total-Body Irradiation, and Autologous Stem-Cell Reconstitution as Consolidation Therapy for High-Risk Ewing’s Sarcoma Does Not Improve Prognosis - Concepedia

Concepedia

Publication | Closed Access

High-Dose Melphalan, Etoposide, Total-Body Irradiation, and Autologous Stem-Cell Reconstitution as Consolidation Therapy for High-Risk Ewing’s Sarcoma Does Not Improve Prognosis

209

Citations

25

References

2001

Year

Paul A. Meyers, Mark Krailo, Marc Ladanyi, Ka‐Wah Chan, Scott L. Sailer, Paul S. Dickman, David L. Baker, Jeffrey Davis, Robert B. Gerbing, Alfred Grovas,

Journal of Clinical Oncology

Abstract

Consolidation with high-dose melphalan, etoposide, TBI, and autologous stem-cell support failed to improve the probability of EFS in this cohort of patients with newly diagnosed metastatic ES.

References

	Year	Citations

Page 1